http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3431488-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84e7b6ec9b1b3c07d91fdba21afe8453
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B29-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B29-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0215
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-037
filingDate 2017-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6554be6cb95c1e4cad7bf8f5def34cc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b1820e7592df195a4fcc810c5f553aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2425ef2fa29200f688e374bddeaa9ec9
publicationDate 2019-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3431488-A1
titleOfInvention Crystal of reduced-form glutathione and method for producing same
abstract According to the present invention, a crystal of reduced glutathione having a reduced content of impurities, particularly L-cysteinyl-L-glycine and a method for producing the same are provided. The present invention relates to a crystal of reduced glutathione, wherein, in a high-performance liquid chromatography (HPLC) analysis, the peak area of L-cysteinyl-L-glycine is 0.02 or less with respect to the peak area of reduced glutathione which is taken as 100.
priorityDate 2016-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443096
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226565477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450481643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22723544
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16213778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID238005000
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24748041
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492952
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID233614020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226492951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587790
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7098621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123938
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419562923
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88245162
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57480389
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23672332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452314179

Total number of triples: 56.